Donglan Luo
Impact in
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Lymphoma Diagnosis and Treatment 9
- Oncology 8
- Viral-associated cancers and disorders 2
- Cancer Treatment and Pharmacology 1
- Co-authors
- Xin-lan Luo (22 shared papers)Yan‐Hui Liu (15 shared papers)Fangping Xu (14 shared papers)Li‐Xu Yan (6 shared papers)Jie Xu (6 shared papers)Fen Zhang (8 shared papers)Xiaolan Zhu (2 shared papers)Ping Mei (4 shared papers)
- Journals
- American Journal of Clinical Pathology (1 paper)Histopathology (1 paper)Clinical Cancer Research (1 paper)Diagnostic Pathology (1 paper)Cancer Medicine (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Donglan Luo
38 papers receiving 476 citations
Peers
Comparison fields: 5 of 76
- Pathology and Forensic Medicine 129
- Cancer Research 90
- Oncology 142
- Genetics 46
- Pulmonary and Respiratory Medicine 75
Countries citing papers authored by Donglan Luo
This map shows the geographic impact of Donglan Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donglan Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donglan Luo more than expected).
Fields of papers citing papers by Donglan Luo
This network shows the impact of papers produced by Donglan Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donglan Luo. The network helps show where Donglan Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Donglan Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 99 | |
| 2 | 2014 | 68 | |
| 3 | 2014 | 43 | |
| 4 | 2014 | 32 | |
| 5 | 2017 | 27 | |
| 6 | 2017 | 25 | |
| 7 | 2019 | 20 | |
| 8 | 2017 | 19 | |
| 9 | 2008 | 19 | |
| 10 | 2009 | 19 | |
| 11 | [Inhibitory effect of refined Amorphophallus konjac on MNNG-induced lung cancers in mice]. | 1992 | 11 |
| 12 | 2022 | 10 | |
| 13 | [Association of HER2 protein expression with clinicopathologic features and prognosis in Chinese patients with gastric carcinoma]. | 2011 | 10 |
| 14 | Intravascular NK/T-cell lymphoma: a series of four cases. | 2017 | 9 |
| 15 | 2016 | 8 | |
| 16 | 2010 | 7 | |
| 17 | 2018 | 7 | |
| 18 | 2019 | 7 | |
| 19 | 2013 | 5 | |
| 20 | [Analysis of diagnosis accuracy of frozen sections in 73 cases of borderline tumor of ovary]. | 2009 | 5 |
About Donglan Luo
Donglan Luo is a scholar working on Pathology and Forensic Medicine, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 38 papers that have together received 485 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Cardiac tumors and thrombi (3 papers), Viral-associated cancers and disorders (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Lung Cancer Treatments and Mutations (2 papers), Cancer Treatment and Pharmacology (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (129 citations), Cancer Research (90 citations), Oncology (142 citations), Genetics (46 citations) and Pulmonary and Respiratory Medicine (75 citations). Donglan Luo has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xin-lan Luo, Yan‐Hui Liu, Fangping Xu, Li‐Xu Yan, Jie Xu, Fen Zhang, Xiaolan Zhu, Ping Mei, Chao Liu and Jie Cheng. Their work appears in journals such as American Journal of Clinical Pathology, Histopathology, Clinical Cancer Research, Diagnostic Pathology and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.